BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

AMBEEPHA

All Eps Dividend Board Agm Q1 Q2 Q3

AMBEEPHA 18-Nov-2021

(Continuation news of AMBEEPHA): Physical counting of cash in hand at Head Office for Tk. 13,548 and Factory for Tk. 4,357 only was done by the management at the year-end. (end)

AMBEEPHA 18-Nov-2021

The auditor of the Ambee Pharmaceuticals Ltd.has given the "Emphasis of matter" paragraphs in the Auditor's Report for the year ended on 30 June, 2021. Emphasis of Matter: In forming our opinion on the Financial Statements, which is not modified, we considered the following matter and the fact that as per note # 10.01, the company reported an amount of Tk. 12,796,385 as cash in hand. (cont.1)

AMBEEPHA 18-Nov-2021

(Continuation news of AMBEEPHA): Regulations, 2015 and in compliance with clause 3 (vii) of the Bangladesh Securities and Exchange Commission (BSEC) Directive No. BSEC/CMRRCD/2021-386/03, dated 14 January 2021. (end)

AMBEEPHA 18-Nov-2021

(Continuation news of AMBEEPHA): July 07, 2020 of the Financial Reporting Council (FRC). 3. As disclosed in note # 21.00, the company has shown Tk. 3,856,352 as Unclaimed Dividend. As the company has no designated bank account for dividend, so we are not sure whether the dividend was paid to the shareholders within the stipulated time as per section 28(1) of Dhaka Stock Exchange (Listing) (cont.3)

AMBEEPHA 18-Nov-2021

(Continuation news of AMBEEPHA): later than nine months from the end of the respective year. 2. As disclosed in note # 18.02, the company has shown Tk. 1,916,358 as Payable to Provident Fund. The amount is carried forward from earlier years. As no financial statement of Provident Fund was made available to us, so we are not sure whether there is any forfeited fund returned to company's account from the contributory provident fund as per notification no. 179/FRC/FRM/2020/2, dated (cont.2)

AMBEEPHA 18-Nov-2021

The auditor of the Ambee Pharmaceuticals Ltd. has given the "Qualified Opinion" paragraphs in the Auditor's Report for the year ended on 30 June, 2021. Basis for Qualified Opinion: 1. As disclosed in note # 20.00, the company has shown Tk. 9,948,826 as liabilities for WPF & WWF which includes prior year's amount of Tk. 9,127,363 that has not been paid by the company to the Fund. As per section 234 (b) of Labour Act, 2006 the company should pay the amount to the WPF & WWF not (cont.1)

AMBEEPHA 18-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 22, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

AMBEEPHA 14-Nov-2021

The Company has further informed that NOCFPS of Tk. (2.27) instead of Tk. (2.77) for the year ended on June 30, 2021. All other information will remain unchanged.

AMBEEPHA 14-Nov-2021

There will be no price limit on the trading of the shares of the Company today (14.11.2021) following its corporate declaration.

AMBEEPHA 14-Nov-2021

The Board of Directors has recommended No dividend for the year ended on June 30, 2021. Date of AGM: 28.12.2021, Time: 11:00 AM, Venue: digital platform. Record date: 05.12.2021. The Company has also reported EPS of Tk. (5.42), NAV per share of Tk. 18.68 and NOCFPS of Tk. (2.77) for the year ended on June 30, 2021 as against Tk. 1.52, Tk. 24.10 and Tk. (4.99) respectively for the same period of the previous year.

Previous Next page